CN111617116A - Preparation method and application of ethanolic extract of rhizoma leaves - Google Patents
Preparation method and application of ethanolic extract of rhizoma leaves Download PDFInfo
- Publication number
- CN111617116A CN111617116A CN202010696363.9A CN202010696363A CN111617116A CN 111617116 A CN111617116 A CN 111617116A CN 202010696363 A CN202010696363 A CN 202010696363A CN 111617116 A CN111617116 A CN 111617116A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- leaves
- ethanolic extract
- larvae
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000469 ethanolic extract Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 241000256844 Apis mellifera Species 0.000 claims abstract description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000007864 aqueous solution Substances 0.000 claims abstract description 5
- 239000000706 filtrate Substances 0.000 claims abstract description 5
- 238000002390 rotary evaporation Methods 0.000 claims abstract description 3
- 201000010099 disease Diseases 0.000 claims description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000001418 larval effect Effects 0.000 claims description 6
- 238000000967 suction filtration Methods 0.000 claims description 4
- 239000000284 extract Substances 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 2
- 239000003242 anti bacterial agent Substances 0.000 description 15
- 229940088710 antibiotic agent Drugs 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 241000257303 Hymenoptera Species 0.000 description 10
- 241000193418 Paenibacillus larvae Species 0.000 description 10
- 239000002609 medium Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 241000193830 Bacillus <bacterium> Species 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000208422 Rhododendron Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000009341 apiculture Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 241000238876 Acari Species 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 241000256836 Apis Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 240000007643 Phytolacca americana Species 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 238000001720 action spectrum Methods 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229940038481 bee pollen Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960004368 oxytetracycline hydrochloride Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000010152 pollination Effects 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
菱的叶子乙醇提取物的制备方法及其应用,涉及蜜蜂的蜜蜂美洲幼虫病防治技术领域。将阴干的菱叶子研磨成粉末后采用乙醇水溶液浸泡,经抽滤,取滤液旋转蒸发,取得菱的叶子乙醇提取物。将该提取物溶解于二甲基亚砜中,用于防治蜜蜂美洲幼虫病。该提取物的使用不存在停药期,在蜂群的整个生产及繁殖阶段均可安全使用,有助于维护蜂群的健康,促进蜂群整体生产力的提高。
The invention relates to a preparation method and application of ethanolic extract from leaves of Rhizoma rhizoma, and relates to the technical field of honeybee American larvae control. The dried rhizoma leaves are ground into powder, soaked in ethanol aqueous solution, filtered by suction, and the filtrate is taken by rotary evaporation to obtain the ethanolic extract of rhizoma leaves. The extract was dissolved in dimethyl sulfoxide and used to control honeybee American larvae. The use of the extract does not have a withdrawal period, and can be safely used in the entire production and reproduction stages of the bee colony, which helps maintain the health of the bee colony and promotes the improvement of the overall productivity of the bee colony.
Description
技术领域technical field
本发明涉及蜜蜂的蜜蜂美洲幼虫病防治技术领域。The invention relates to the technical field of honeybee American larval disease control.
背景技术Background technique
蜜蜂是重要的经济昆虫,蜜蜂是传花授粉媒介的重要组成部分,是构成全球生物多样性的重要组成成分,它们对作物、水果和野生植物的授粉活动,使其成为世界范围内最重要的传花授粉昆虫之一,不仅对于农业生产意义重大,更是在维系生物多样性中扮演着重要角色。同时,蜜蜂生产的蜂蜜、蜂花粉、蜂王浆、蜂胶等蜜蜂产品也是重要的保健食品和化工原料。Bees are important economic insects, and bees are an important part of pollinators and constitute an important component of global biodiversity. Their pollination activities on crops, fruits and wild plants make them the most important worldwide. One of the pollinators is not only of great significance to agricultural production, but also plays an important role in maintaining biodiversity. At the same time, honey, bee pollen, royal jelly, propolis and other bee products produced by bees are also important health food and chemical raw materials.
美洲幼虫病(American Foulbrood,AFB,又称美洲幼虫腐臭病、美洲幼虫腐烂病),简称美腐病,是一种恶性的蜜蜂幼虫传染病,在世界范围内均有发生。美洲幼虫病与幼虫芽孢杆菌感染有关,该病的发生与幼虫的抵抗力有很大的关系,主要是通过已经感染的蜜蜂饲喂蜂群幼虫,使得该病迅速在蜂群的幼虫间快速传播。通常现代的处置方式是在蜂群确诊该病后需要就地焚烧处理,防止疾病扩散。AFB的病原是幼虫芽孢杆菌(Paenibacilluslarvae),属于一种革兰氏阳性细菌。蜜蜂幼虫对幼虫芽孢杆菌的敏感性随着日龄的增长而降低,在每个感染的幼虫体内能产生数以亿计的、具有感染能力的孢子,由于其孢子对热和化学物质有极强的抵抗力,可存活长达35年之久,导致AFB感染后,幼虫残骸的鳞片、蜂箱、产品和设备都是潜在的污染源。American Foulbrood (AFB, also known as American larvae foul disease, American larvae rot disease), referred to as American rot disease, is a vicious bee larval infectious disease that occurs worldwide. American larval disease is related to Bacillus larvae infection. The occurrence of the disease is closely related to the resistance of the larvae. It is mainly fed by the infected bees to the larvae of the colony, which makes the disease spread rapidly among the larvae of the colony. . Usually the modern disposal method is to incinerate the bee colony after diagnosis of the disease to prevent the disease from spreading. The causative agent of AFB is Paenibacillus larvae, a Gram-positive bacterium. The susceptibility of honeybee larvae to Bacillus larvae decreases with age, producing hundreds of millions of infectious spores in each infected larvae due to their extreme resistance to heat and chemicals , which can survive for up to 35 years, leading to AFB infection. Scales, beehives, products and equipment of larval remains are all potential sources of contamination.
目前用于治疗AFB的抗生素很多,如磺胺类药物、盐酸土霉素、四环素、青霉素、链霉素、红霉素、卡那霉素、红霉素、泰乐霉素等,药物通常配用糖浆或者蜜水,勾兑后喷施。每次糖浆和蜜水用量,每脾用100-150mL,间隔4-5d喷施1次。但是,连续使用抗生素有污染蜂产品的可能。为此,用药用量要控制得当,尤其要避开生产季节,防治抗生素在蜂产品中的残留。而且,尽量选择早春或晚秋,治疗效果则会更好些。然而,总体来看,抗生素会在蜂产品中残留,严重影响蜂产品的质量,给人类的健康造成威胁。除此之外,抗生素还会使蜜蜂病原体的耐药性增强,导致病原体产生相应的变异,使得蜂群患病更加严重。There are many antibiotics currently used to treat AFB, such as sulfonamides, oxytetracycline hydrochloride, tetracycline, penicillin, streptomycin, erythromycin, kanamycin, erythromycin, tylosin, etc. Syrup or honey water, spray after blending. The dosage of syrup and honey water is 100-150mL per spleen, and sprayed once every 4-5d. However, continuous use of antibiotics has the potential to contaminate bee products. To this end, the dosage of the drug should be properly controlled, especially the production season should be avoided to prevent the residue of antibiotics in bee products. Moreover, try to choose early spring or late autumn, the treatment effect will be better. However, in general, antibiotics will remain in bee products, seriously affecting the quality of bee products and posing a threat to human health. In addition, antibiotics can also increase the resistance of bee pathogens, causing the pathogens to mutate accordingly, making the bee colony more sick.
可见,通过使用抗生素对AFB进行防控,往往因超量使用,或者使用抗生素时间不当很容易造成蜂产品中抗生素残留超标,抗生素只能抑制临床症状并不能对孢子发挥作用,且接触了抗生素的幼虫和成蜂,其寿命明显缩短,更严重的是耐药性的产生是导致其对AFB已无法有效地控制主要原因,在全世界范围内给养蜂者造成了巨大的经济损失,与此同时也直接影响了人们食品安全问题。It can be seen that the use of antibiotics to prevent and control AFB is often caused by excessive use or improper use of antibiotics, which can easily lead to excessive antibiotic residues in bee products. Antibiotics can only suppress clinical symptoms and cannot act on spores. The life span of larvae and adult bees is significantly shortened, and more seriously, the emergence of drug resistance is the main reason that they cannot effectively control AFB, causing huge economic losses to beekeepers all over the world. At the same time, it also directly affects people's food safety issues.
为了减少养蜂生产中抗生素的使用,人们采用植物进行蜂病的防治。如山西振兴鱼蜂药业公司的纯中药制剂-毒螨菌一次净、甘肃天水汇涛蜂业公司的中草药植物粉剂-健蜂抗螨香粉、山西卫鹏制药有限公司的中草药制剂-蜂康等。不过,目前这些治疗蜂病的产品从种类和疗效上都不能较好满足绿色蜂业的发展需要。还有通过拮抗性细菌发挥生物防控作用,如Evans and Armstrong首次成功地利用培养的P.larvae对幼虫芽孢杆菌引起的AFB进行了生物防控;日本研发的原露技术,对防治蜂病,特别是爬蜂病、大肚病、幼虫病和蜜蜂痢疾等有明显的预防效果,不过其作用谱窄、药效慢、持效短、且易受外界条件的影响。In order to reduce the use of antibiotics in beekeeping, people use plants to control bee diseases. For example, the pure Chinese medicine preparation of Shanxi Zhenxing Yubee Pharmaceutical Co., Ltd.-Dox mites once clean, the Chinese herbal plant powder of Gansu Tianshui Huitao Bee Industry Co., Ltd.-Jianbee anti-mite fragrance powder, the Chinese herbal medicine preparation of Shanxi Weipeng Pharmaceutical Co., Ltd.-Fengkang Wait. However, at present, these products for treating bee diseases cannot well meet the development needs of green bee industry in terms of type and curative effect. There are also biological control effects through antagonistic bacteria. For example, Evans and Armstrong successfully used the cultured P. larvae for the first time to carry out biological control of AFB caused by Bacillus larvae; In particular, it has obvious preventive effect on crawling bee disease, pot stomach disease, larvae disease and bee dysentery, but its action spectrum is narrow, the drug effect is slow, the lasting effect is short, and it is easily affected by external conditions.
目前在全世界范围蜜蜂的种群数量逐年递减,在引起蜜蜂种群锐减的诸多因素中,病原体对抗生素产生耐药性,是导致蜂群疾病防控失败的主要原因。随着抗生素类药物的长期使用,蜂群耐药性病菌不断出现,药物抗性问题日显突出,而因为药效逐渐降低、抗生素的用量又不断加大,由此形成了一个恶性循环。At present, the number of bee populations around the world is decreasing year by year. Among the many factors that cause the sharp decline of bee populations, the resistance of pathogens to antibiotics is the main reason for the failure of bee colony disease prevention and control. With the long-term use of antibiotics, bee colony-resistant bacteria continue to emerge, and the problem of drug resistance becomes increasingly prominent. Because the efficacy of drugs gradually decreases, the dosage of antibiotics continues to increase, thus forming a vicious circle.
发明内容SUMMARY OF THE INVENTION
本发明目的在于提出一种天然的、能够替代抗生素的植物源的用于防治蜜蜂美洲幼虫病的菱叶子的乙醇提取物。The purpose of the present invention is to provide a natural, plant-derived ethanol extract of Rhizoma chinensis that can replace antibiotics for preventing and treating Bee American larvae.
本发明菱的叶子乙醇提取物的制备方法是:将阴干的菱叶子研磨成粉末后采用乙醇水溶液浸泡,经抽滤,取滤液旋转蒸发,取得菱的叶子乙醇提取物。The preparation method of the leaf ethanol extract of Rhizoma Rhizoma of the present invention is as follows: the dried Rhizoma Rhizoma leaves are ground into powder, soaked in ethanol aqueous solution, filtered by suction, and the filtrate is obtained by rotary evaporation to obtain the leaf ethanol extract of Rhizoma Rhizoma.
所述菱的叶子乙醇提取物的含水量为5~10wt.%。The water content of the ethanolic extract of the leaves of Rhizoma Rhizoma is 5-10 wt.%.
所述乙醇水溶液中乙醇的体积百分数为75~85%。The volume percentage of ethanol in the ethanol aqueous solution is 75-85%.
本发明工艺简单,经试验证实其对蜜蜂幼虫芽孢杆菌具有抑制效果。The process of the invention is simple, and it is proved by experiments that it has an inhibitory effect on the honeybee larvae Bacillus.
本发明另一目的是提出上述制备方法取得的菱的叶子乙醇提取物的应用。Another object of the present invention is to propose the application of the ethanolic extract of the leaves of Rhizoma rhizoma obtained by the above preparation method.
将所述菱的叶子乙醇提取物溶解于二甲基亚砜中,用于防治蜜蜂美洲幼虫病。The ethanolic extract of the leaves of the rhizoma rhizoma is dissolved in dimethyl sulfoxide, and is used for preventing and treating honeybee American larvae.
经试验证实,不同的菱的叶子乙醇提取物都对蜜蜂幼虫芽孢杆菌具有抑制效果,这为开发防治AFB提供了天然药物及饲料奠定了基础,同时也为绿色养蜂生产寻找出新型的、天然的、能够替代抗生素的植物源制剂。It has been confirmed by experiments that the ethanolic extracts of different rhizoma leaves have inhibitory effects on Bacillus larvae, which lays the foundation for the development of natural medicines and feeds for the prevention and treatment of AFB, and also provides new and natural products for green beekeeping. Plant-derived preparations that can replace antibiotics.
更优越的是菱的叶子乙醇提取物的使用不存在停药期,在蜂群的整个生产及繁殖阶段均可安全使用,有助于维护蜂群的健康,促进蜂群整体生产力的提高。植物源抗生素替代制剂可减少抗生素的使用、降低蜂产品中抗生素的残留,提高蜂产品的产量和质量。What's more superior is that there is no withdrawal period for the use of the ethanolic extract of the leaves of the rhizome, and it can be safely used in the entire production and reproduction stages of the bee colony, which helps to maintain the health of the bee colony and promote the improvement of the overall productivity of the bee colony. Plant-derived antibiotic substitution formulations can reduce the use of antibiotics, reduce antibiotic residues in bee products, and improve the yield and quality of bee products.
附图说明Description of drawings
图1为菌落PCR产物的琼脂糖凝胶电泳图。Figure 1 is an agarose gel electrophoresis image of colony PCR products.
图2为菱叶子提取物的抑菌效果图。Figure 2 is a graph showing the antibacterial effect of the extract of Rhizoma rhizoma leaves.
具体实施方式Detailed ways
1、材料与方法:1. Materials and methods:
1.1实验材料1.1 Experimental materials
1.1.1实验样本的采集1.1.1 Collection of experimental samples
蜜蜂成虫及幼虫采集于当地转地放蜂的蜂场,在已经有临床症状的蜂群中,取成年有临床症状的蜜蜂及有临床症状的幼虫分别放入无菌的指型管中,置于冰上。同时,收取来自同一蜂场看起来是健康的蜂箱及巢脾的成年蜜蜂及幼虫带回,并置于-70℃冷冻保存。Adult honeybees and larvae were collected from the local bee farms where the bees were relocated. In the bee colony with clinical symptoms, adult bees with clinical symptoms and larvae with clinical symptoms were taken into sterile finger-shaped tubes. on ice. At the same time, adult bees and larvae from healthy-looking hives and comb spleens from the same beehive were collected and brought back, and stored at -70°C for cryopreservation.
1.1.2菱的叶子乙醇提取物的制备1.1.2 Preparation of the ethanolic extract of the leaves of Rhizoma
将采集来的阴干的菱叶子研磨,分别称取20g粉末,按照1:20的质量比例分别用体积百分数为75~85%的乙醇水溶液浸泡2h后抽滤,再将抽滤后的粉末继续浸泡24h后再抽滤,如此反复3、4次,合并各抽滤所得的滤液,利用旋转蒸发仪减压浓缩至粘稠状,即得菱的叶子乙醇提取物。Grind the collected dried rhizoma leaves, weigh 20 g of powder respectively, soak them in an aqueous ethanol solution with a volume percentage of 75 to 85% for 2 hours, and then filter the powders after immersion in a mass ratio of 1:20. After 24 hours, suction filtration is repeated, repeated 3 or 4 times, the filtrates obtained by suction filtration are combined, and the filtrate obtained by suction filtration is concentrated to a viscous state under reduced pressure using a rotary evaporator to obtain the ethanolic extract of the leaves of Rhizoma rhizoma.
经检测取得的菱的叶子乙醇提取物的含水量为5~10wt.%。The water content of the ethanolic extract of the leaves of Rhizoma rhizoma obtained through testing is 5-10 wt.%.
1.1.3实验试剂的配置1.1.3 Configuration of experimental reagents
制备Luria-Bertani液体培养基:将酵母抽提物1g、胰化蛋白胨0.5g和氯化钠0.5g混合后,采用缓冲液调整pH值至7.2,加入适量双蒸水定容到100mL,高压灭菌,降温,取得Luria-Bertani液体培养基。Preparation of Luria-Bertani liquid medium: Mix 1 g of yeast extract, 0.5 g of tryptone and 0.5 g of sodium chloride, adjust the pH value to 7.2 with buffer, add an appropriate amount of double-distilled water to make up to 100 mL, and autoclave Bacteria, cool down, and obtain Luria-Bertani liquid medium.
制备蜜蜂幼虫芽孢杆菌的培养粉:将25%蜂王浆、50%雄蜂蛹粉、15%蛋白粉和10%蜂王幼虫粉混合,合计100%,经冷冻干燥,取得蜜蜂幼虫芽孢杆菌的培养粉。Preparation of Bacillus honeybee larvae culture powder: Mix 25% royal jelly, 50% drone pupa powder, 15% protein powder and 10% queen bee larvae powder to make a total of 100%, freeze-dry to obtain Bacillus bee larvae culture powder.
将蜜蜂幼虫芽孢杆菌的培养粉分包装、密封后置于-20-20℃保存。The culture powder of Bacillus bee larvae was packaged and sealed and stored at -20-20°C.
1.1.4实验仪器1.1.4 Experimental Instruments
南京优普环保设备有限公司制水机;METTLERTOLEDO电子天平;SHEL LAB水浴锅;5834R型冷冻离心机;Telstar LyoQuest冻干机;GHX9160B-1培养箱;超低温冰箱;SW-CJ-2HD超净工作台。Nanjing Youpu Environmental Protection Equipment Co., Ltd. water maker; METTLERTOLEDO electronic balance; SHEL LAB water bath; 5834R refrigerated centrifuge; Telstar LyoQuest freeze dryer; GHX9160B-1 incubator; ultra-low temperature refrigerator; SW-CJ-2HD ultra-clean workbench .
1.2.实验方法1.2. Experimental method
1.2.1蜜蜂样本的处理1.2.1 Processing of honeybee samples
取自已经发病蜂群的幼虫采用PBS(幼虫和PBS的混合比为10g∶100ml)匀浆得悬浮液,然后在80℃下加热10min或95-96℃加热3-5min。The larvae from the infected bee colonies were homogenized with PBS (the mixing ratio of larvae and PBS was 10g:100ml) to obtain a suspension, and then heated at 80°C for 10min or 95-96°C for 3-5min.
将已经发病蜂场的成年蜜蜂用PBS充分荡洗,所得到的样品分为三份,每份分别进行三种处理:不经加热处理;在80℃下热处理10min;在95℃下热处理3min。The adult bees in the infected hive were washed with PBS, and the obtained samples were divided into three parts, and each part was treated with three kinds of treatments: no heat treatment; heat treatment at 80 °C for 10 min; heat treatment at 95 °C for 3 min.
将已经发病蜂场的成年蜜蜂用PBS充分荡洗,取出肠子,采用PBS(肠子和PBS的混合比为10g∶100ml)匀浆30sec。再将匀浆液通过滤纸过滤、离心,取沉淀再重新悬浮在PBS中。The adult bees in the diseased hive were thoroughly washed with PBS, and the intestines were taken out and homogenized with PBS (the mixing ratio of intestines and PBS was 10 g: 100 ml) for 30 sec. The homogenate was then filtered through filter paper, centrifuged, and the pellet was resuspended in PBS.
1.2.2细菌的分离培养1.2.2 Isolation and culture of bacteria
将蜜蜂幼虫芽孢杆菌的培养粉溶于PBS(培养粉和PBS的混合比为10g∶100ml),并用一次性滤器除菌后,取得蜜蜂芽孢杆菌的培养液。The culture powder of Bacillus bee larvae was dissolved in PBS (the mixing ratio of culture powder and PBS was 10g:100ml) and sterilized with a disposable filter to obtain the culture solution of Bacillus bee.
将蜜蜂芽孢杆菌的培养液和液体Luria-Bertarfi培养基按体积占比为20%的比例混合,取得培养液。The culture solution of Bacillus apis and the liquid Luria-Bertarfi medium were mixed in a proportion of 20% by volume to obtain a culture solution.
将以上培养液分别涂抹于无菌培养盘上,再将经过1.2.1处理的样品分别涂抹于各个培养基上,在37℃下培养1~3天。The above culture solutions were smeared on sterile culture plates, and then the samples treated in 1.2.1 were smeared on each culture medium, and cultured at 37°C for 1 to 3 days.
结果发现:各无菌培养盘中细菌生长旺盛,菌落聚集成团。The results showed that the bacteria in each sterile culture plate grew vigorously, and the colonies aggregated into clusters.
说明:在以上培养粉中的确含有幼虫芽孢杆菌生长所需的物质,并且将其作为营养组分添加于普通LB培养基后,可以用于幼虫芽孢杆菌的实验室培养。Description: The above culture powder does contain substances required for the growth of Bacillus larvae, and it can be used for laboratory culture of Bacillus larvae after adding it as a nutrient component to ordinary LB medium.
在各份培养基上挑取单菌落再移入与对应的相同的培养液中进行扩大培养。Pick a single colony on each medium and transfer it into the same medium as the corresponding medium for expansion.
通常幼虫芽孢杆菌单菌落小、规则、大多粗糙、扁平或凸起,呈白色至米色。Usually larval Bacillus single colonies are small, regular, mostly rough, flat or raised, white to beige in color.
1.2.3细菌DNA的提取、扩增1.2.3 Extraction and amplification of bacterial DNA
对各个扩大培养后的单菌落DNA进行提取,方法如下:用灭菌牙签挑取各培养基上长出的单个菌落,将其悬浮在50μL蒸馏水中,加热至95℃维持15min,离心5min后,取1-5μL上清液用作PCR的模板。The DNA of each single colony after expanded culture was extracted as follows: pick a single colony grown on each medium with a sterilized toothpick, suspend it in 50 μL of distilled water, heat it to 95 °C for 15 min, and centrifuge for 5 min. Take 1-5 μL of the supernatant to use as a template for PCR.
PCR(50μL)反应体系,其中包括:1-5μL模板DNA;50pmol/L正向(AFB-F)和反向引物(AFB-R);包括10nmol/L dNTPs、2mM MgCl2、1-2.5U的Taq聚合酶的Mix;ddH2O。PCR (50μL) reaction system, including: 1-5μL template DNA; 50pmol/L forward (AFB-F) and reverse primers (AFB-R); including 10nmol/L dNTPs, 2mM MgCl 2 , 1-2.5U Mix of Taq polymerase; ddH 2 O.
扩增条件:95℃预变性1min,93℃变性1min,55℃退火30sec,72℃延伸1.5min,30个循环后于72℃延伸5min。Amplification conditions: pre-denaturation at 95 °C for 1 min, denaturation at 93 °C for 1 min, annealing at 55 °C for 30 sec, extension at 72 °C for 1.5 min, and extension at 72 °C for 5 min after 30 cycles.
1.2.4菌落PCR鉴定1.2.4 Colony PCR identification
对培养基上生长的细菌单克隆,进行菌落PCR鉴定:用0.8%琼脂糖凝胶电泳检测PCR产物,在约1100bp位置附近出现目的条带,见图1所示。Colony PCR identification was performed on the bacterial clones grown on the medium: PCR products were detected by 0.8% agarose gel electrophoresis, and the target band appeared near the position of about 1100 bp, as shown in Figure 1 .
图1中泳道M为DL2000 DNA marker,泳道2为阴性对照,泳道1,3-8为菌落PCR的扩增产物。In Figure 1, lane M is the DL2000 DNA marker,
由菌落PCR产物的琼脂糖凝胶电泳图说明:以上经过1.2.1处理的样品都携带AFB的幼虫芽孢杆菌。From the agarose gel electrophoresis of the colony PCR products, it is indicated that the samples processed in 1.2.1 above all carry Bacillus larvae of AFB.
1.2.5菱的叶子乙醇提取物抑菌效果的测定1.2.5 Determination of the antibacterial effect of the ethanolic extract of the leaves
取菱的叶子乙醇提取物用二甲基亚砜溶解配成1g/mL的溶液,然后再用二甲基亚砜进行梯度稀释,使其浓度成为200mg/mL、100mg/mL、50mg/mL、25mg/mL和12.5mg/mL 5个不同浓度梯度的菱叶子乙醇提取物。Take the ethanolic extract of the leaves of the rhizome and dissolve it in dimethyl sulfoxide to make a solution of 1 g/mL, and then carry out gradient dilution with dimethyl sulfoxide to make the concentration of 200mg/mL, 100mg/mL, 50mg/mL, 25mg/mL and 12.5mg/
将以上培养液分别涂抹于无菌培养盘上,再以经过1.2.1处理的样品分别进行涂布平板,待菌液干后,用灭菌的枪头对每份菌液干后的涂布平板戳出小洞若干,然后在小洞中分别滴入上述5个浓度梯度的菱叶子乙醇提取物,同时留下不滴加菱叶子乙醇提取物作为对照组。Apply the above culture solution on the sterile culture plate respectively, and then use the samples treated in 1.2.1 to coat the plate respectively. After the bacteria solution is dry, use a sterilized pipette tip to coat the dried bacteria solution. Poke a few small holes on the plate, and then drop the ethanol extract of the leaves of Rhizoma Rhizoma with the above 5 concentration gradients respectively in the small holes, while leaving the ethanol extract of Rhizoma Rhizoma leaves without dripping as a control group.
然后将以上各培养盘置入37℃培养箱中培养3天。Then each of the above culture plates was placed in a 37°C incubator for 3 days.
观察结果:用十字交叉法测量抑菌圈直径,每个抑菌圈测量3次,取其平均值作为最后的抑菌圈直径。Observation results: The diameter of the inhibition zone was measured by the cross method, and each inhibition zone was measured 3 times, and the average value was taken as the final inhibition zone diameter.
2、实验结果:2. Experimental results:
在滴加不同菱的叶子乙醇提取物浓度的培养盘上的小洞发生透明抑菌圈直径扩大现象,如图2所示。The diameter of the transparent bacteriostatic zone expanded in the small holes on the culture plate to which different concentrations of the ethanol extract of the leaves of the rhizoma were added dropwise, as shown in Figure 2.
而不滴加菱叶子乙醇提取物的培养盘上的小洞没有发生变化。The small holes on the culture plate without the dropwise addition of the ethanolic extract of Rhododendron leaves did not change.
可见菱的叶子乙醇提取物对幼虫芽孢杆菌均表现出一定的抑菌活性,即便在较低浓度下也表现出一定的抑菌效果。It can be seen that the ethanolic extracts of the leaves of Rhizoma Rhizoma have a certain bacteriostatic activity against Bacillus larvae, even at a lower concentration.
下表为不同菱的叶子乙醇提取物浓度对应的抑菌效果对比表。The following table is a comparison table of the antibacterial effect corresponding to the concentration of the ethanolic extract of different rhizoma leaves.
由上表可见,菱的叶子乙醇提取物浓度越高抑菌效果越好。It can be seen from the above table that the higher the concentration of the ethanolic extract of the leaves, the better the bacteriostatic effect.
结论:菱的叶子乙醇提取物可用于防治AFB。CONCLUSION: The ethanolic extract of the leaves of Rhizoma Rhizoma can be used to control AFB.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010696363.9A CN111617116A (en) | 2020-07-20 | 2020-07-20 | Preparation method and application of ethanolic extract of rhizoma leaves |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010696363.9A CN111617116A (en) | 2020-07-20 | 2020-07-20 | Preparation method and application of ethanolic extract of rhizoma leaves |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111617116A true CN111617116A (en) | 2020-09-04 |
Family
ID=72267889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010696363.9A Withdrawn CN111617116A (en) | 2020-07-20 | 2020-07-20 | Preparation method and application of ethanolic extract of rhizoma leaves |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111617116A (en) |
-
2020
- 2020-07-20 CN CN202010696363.9A patent/CN111617116A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Antúnez et al. | Efficacy of natural propolis extract in the control of American Foulbrood | |
Zheng et al. | Current status of the beekeeping industry in China | |
ITMI20100776A1 (en) | METHOD FOR PROPHYLAXIS AND CONTROL OF BEE PATOGEN INFECTIONS, AND ITS COMPOSITION | |
CN113265350A (en) | Bifidobacterium W8118 and application thereof | |
Vung et al. | Breeding and selection for resistance to sacbrood virus for Apis cerana | |
CN109393254B (en) | Compositions and methods for enhancing insect immunity | |
RU2552672C1 (en) | Composition for stimulation of development of bee families, prevention and treatment of ascospherosis | |
Gajger et al. | Experimental treatment of nosema disease with “Nozevit” phyto-pharmacological preparation | |
KR101866620B1 (en) | Composition comprising an extract of Artemisia lvandulaefolial or Aster scaberl for treating insect disease | |
CN111808771A (en) | Laboratory culture powder, preparation method and application of Bacillus americana larvae | |
CN111617116A (en) | Preparation method and application of ethanolic extract of rhizoma leaves | |
Milián et al. | Use of microbial additives in apiculture | |
CN111759888A (en) | Preparation method and application of ethanol extract of Gorgon leaf | |
Chemurot | The distribution, infestation levels and effects of honeybee parasites and pathogens on colony performance in two agro-ecological zones of Uganda | |
Bahreini et al. | A study of the efficacy of formic acid in controlling Varroa destructor and its correlation with temperature in Iran | |
Salimi et al. | Propolis, royal jelly and pollen from beehive have antibacterial effect on aquatic pathogenic bacterial isolates | |
Gajger et al. | Nozevit patties” treatment of honey bees (Apis mellifera) for the control of Nosema ceranae disease | |
CN111297884B (en) | Application of Adenosine in Prevention and Control of Honeybee Virus Infection | |
Vung et al. | Controlling sacbrood virus disease in Apis cerana colonies with biological methods in Korea | |
Mărghitaș et al. | The effect of Plant supplements on the development of artificially weaken bee families | |
KR20210155118A (en) | A COMPOSITION FOR INHIBITING BACTERIA AND INCREASING SURVIVAL OF BEE COMPRISING MICROORGANISM FROM SOCIAL CROP OF Apis mellifera | |
KR101847532B1 (en) | A composition for prevention and treatment of honey bee diseases | |
CN111265596B (en) | Traditional Chinese medicine composition for preventing and treating middle capsule disease | |
Urinova et al. | Diagnoses, prevention, and treatment of rotting disease and ascospherosis infectious of honeybees in andijan region | |
Simonyan | Study of Acute Bee Paralysis Virus in Some Regions of the Republic of Armenia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200904 |